InterMune, Inc. (ITMN)

PDTBiotech (83.79) Submitted: 2/06/08 3:03 PM : Start Price: $16.46 ITMN Score: -20.13

Intermune, Inc. (ITMN) develops drugs for the treatment of lung and liver diseases. I’m picking ITMN as my first short on CAPS because I’m struck by how little this company has to offer. It’s notoriously difficult to predict when these sorts of com...

Report this Post Replies: 4 | Reply | Permalink

NetscribeBiotech (78.89) Submitted: 3/12/07 5:09 AM : Start Price: $22.04 ITMN Score: 4.53

InterMune, Inc. (InterMune) is a biopharmaceutical company focused on developing and commercializing therapies in pulmonology and hepatology. The company derives its revenues primarily from its solitary product Actimmune which is meant to treat patie...

Report this Post Replies: 0 | Reply | Permalink

asabah (84.86) Submitted: 6/27/07 10:25 PM : Start Price: $25.93 ITMN Score: 11.28

Finding a single compound as an inhibitor of Hepititis C virus (HCV) is not an easy task. HCV has 6 different genotypes and within each genotype there are a number of subtypes. It is an RNA virus which mutates very quickly. Therefore in a single infe...

Report this Post Replies: 0 | Reply | Permalink

RBBioContest06 (< 20) Submitted: 5/31/06 10:29 PM : Start Price: $15.85 ITMN Score: 19.25

Picked by lanoush

Report this Post Replies: 0 | Reply | Permalink

TMFBreakerBrian (99.68) Submitted: 9/06/06 6:42 AM : Start Price: $16.63 ITMN Score: 13.57

As Vertex moves forward with their Hep-C protease inhibitor all biotechs in this space will experience rising share prices and Intermune will be one of them.

Report this Post Replies: 0 | Reply | Permalink

TMFBreakerJava (99.25) Submitted: 7/28/06 7:29 PM : Start Price: $16.06 ITMN Score: 18.54

This biotech was chosen by RB guru and perennial CAPS all-star Charly Travers. It is even cheaper now than when he reccommended it. For good measure, the whole biotech market has been beaten up lately. Good stock and good timing it seems to me.

Report this Post Replies: 1 | Reply | Permalink

lanoush (64.52) Submitted: 1/12/07 1:16 PM : Start Price: $32.20 ITMN Score: -29.60

ITMN's hep C product has a chance to become a standard treatment, alongside VRTX's product. Recently a quick test for Hep C was introduced and is being marketed to doctors. It could make it more common for Hep C testing to become a standard screen, s...

Report this Post Replies: 0 | Reply | Permalink

TMFBreakerCharly (90.16) Submitted: 4/25/06 12:43 AM : Start Price: $17.50 ITMN Score: 10.60

Company has a very attractive hepatitis drug about to enter clinical trials. While it is very early stage the reward here is huge. Late '07 is when we should know how things stand.

Report this Post Replies: 0 | Reply | Permalink

mutantninjaturtl (68.69) Submitted: 2/06/07 1:12 AM : Start Price: $35.92 ITMN Score: -34.24

Cawabonga!!!!

Report this Post Replies: 0 | Reply | Permalink

1crazystunt (42.09) Submitted: 12/27/06 3:23 PM : Start Price: $30.17 ITMN Score: -25.67

They are on track and headed in the right direction

Report this Post Replies: 0 | Reply | Permalink